BioFire® Blood Culture Identification 2 (BCID2) Panel by Biofire Diagnostics

Manufacturer Biofire Diagnostics  |  Available Worldwide
The syndromic BioFire® Blood Culture Identification 2 (BCID2) Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes—all with one test and with results available in about an hour from positive blood culture.


BioFire® Blood Culture Identification 2 (BCID2) Panel by Biofire Diagnostics product image
BioFire® Blood Culture Identification 2 (BCID2) Panel
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

Quickly identifying the cause of bloodstream infections may help clinicians more rapidly and appropriately manage patient therapy. With 43 targets, the newly expanded BioFire BCID2 Panel detects bloodstream pathogens and antimicrobial resistance genes directly from positive blood cultures. The panel features broadened inclusivity for Enterobacterales, new assays for fungal and anaerobic pathogens, and additional identification of coagulase-negative Staphylococcus species. The BioFire BCID2 Panel menu includes 10 antimicrobial resistance genes, including a novel MREJ target to allow for more specific MRSA identification.

  • Detects and identifies 26 bacterial targets, 7 yeast pathogens, and 10 antimicrobial resistance genes
  • Results available in about 1 hour
  • Available for use on all BioFire® FilmArray® System instruments